Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Halldin

Showing results (81-90 of 235) with videos related to

Pageof 24
Sort By:
Neuroscience Letters|April 15, 1991
Dopamine D2 receptors in the rat, monkey and the post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298C Köhler, H Ericson, T Högberg, et al.
The American Journal of Psychiatry|February 1, 1995
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoateS Nyberg, L Farde, C Halldin, et al.
Nuclear Medicine and Biology|July 1, 1997
Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptorsH Hall, C Halldin, E Jerning, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patientsL Farde, S Nyberg, G Oxenstierna, et al.
Neuroimage|February 15, 2001
Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brainH Ito, Y Sudo, T Suhara, et al.
Neurology|April 28, 2004
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsyI Savic, P Lindström, B Gulyás, et al.
Neuroimage|March 21, 2016
Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography dataP Fazio, M Schain, K Varnäs, et al.
Acta Pharmaceutica Nordica|January 1, 1990
Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptorsT Högberg, P Ström, H Hall, et al.
Synapse (New York, N.Y.)|February 1, 1994
PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brainL Farde, C Halldin, L Müller, et al.
European Journal of Nuclear Medicine|January 1, 1990
Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurementsG Blomqvist, S Pauli, L Farde, et al.
Pageof 24

Showing results (81-90 of 235) with videos related to

Sort By:
Pageof 24
Neuroscience Letters|April 15, 1991
Dopamine D2 receptors in the rat, monkey and the post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298C Köhler, H Ericson, T Högberg, et al.
The American Journal of Psychiatry|February 1, 1995
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoateS Nyberg, L Farde, C Halldin, et al.
Nuclear Medicine and Biology|July 1, 1997
Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptorsH Hall, C Halldin, E Jerning, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patientsL Farde, S Nyberg, G Oxenstierna, et al.
Neuroimage|February 15, 2001
Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brainH Ito, Y Sudo, T Suhara, et al.
Neurology|April 28, 2004
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsyI Savic, P Lindström, B Gulyás, et al.
Neuroimage|March 21, 2016
Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography dataP Fazio, M Schain, K Varnäs, et al.
Acta Pharmaceutica Nordica|January 1, 1990
Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptorsT Högberg, P Ström, H Hall, et al.
Synapse (New York, N.Y.)|February 1, 1994
PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brainL Farde, C Halldin, L Müller, et al.
European Journal of Nuclear Medicine|January 1, 1990
Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurementsG Blomqvist, S Pauli, L Farde, et al.
Pageof 24